Cannabis Users with First-Episode Psychosis Had Lower Metabolic Syndrome Rates
Among 404 first-episode psychosis patients, those who used cannabis at any point during the study were less likely to develop metabolic syndrome and tended to have better triglyceride and HDL cholesterol profiles.
Quick Facts
What This Study Found
In the RAISE-ETP program (n=404), cannabis users had similar baseline metabolic syndrome rates as abstainers but showed lower triglycerides, elevated HDL, and were less likely to develop metabolic syndrome over the study period.
Key Numbers
404 participants in RAISE-ETP; similar baseline metabolic syndrome rates; cannabis users had lower triglycerides and higher HDL; cannabis users less likely to develop metabolic syndrome over study period.
How They Did This
Retrospective analysis of 404 participants in the Recovery After Initial Schizophrenia Episode-Early Treatment Program (RAISE-ETP), using multiple logistic regression to examine the association between cannabis use and metabolic syndrome.
Why This Research Matters
Metabolic syndrome is a major concern for psychosis patients on antipsychotics. If cannabis use is associated with lower metabolic risk, understanding the mechanism could lead to new approaches for managing medication side effects.
The Bigger Picture
This finding adds to a growing body of evidence suggesting cannabis may have metabolic effects that counteract some of the weight and lipid changes caused by antipsychotic medications, though the clinical implications remain unclear.
What This Study Doesn't Tell Us
Retrospective design; potential confounders including diet, exercise, and medication adherence; cannabis use was not randomized; cannot determine causal mechanism.
Questions This Raises
- ?Is the metabolic benefit due to cannabis itself or to behavioral differences among users?
- ?Could cannabinoid-based interventions help manage antipsychotic-related metabolic syndrome?
Trust & Context
- Key Stat:
- Cannabis users with first-episode psychosis were less likely to develop metabolic syndrome
- Evidence Grade:
- Retrospective analysis of a well-characterized treatment program, limited by observational design and potential confounders.
- Study Age:
- Data from the RAISE-ETP program.
- Original Title:
- Cannabis use and metabolic syndrome among clients with first episode psychosis.
- Published In:
- Early intervention in psychiatry, 15(4), 1051-1055 (2021)
- Database ID:
- RTHC-03554
Evidence Hierarchy
Looks back at existing records to find patterns.
What do these levels mean? →Frequently Asked Questions
Does cannabis protect against metabolic syndrome?
In this study of first-episode psychosis patients, cannabis users had lower triglycerides, higher HDL, and lower rates of metabolic syndrome. However, the study cannot prove cannabis caused these benefits, and other factors may explain the association.
What is metabolic syndrome?
A cluster of conditions including high blood pressure, high blood sugar, excess body fat, and abnormal cholesterol that increase the risk of heart disease, stroke, and diabetes. It is a common side effect of antipsychotic medications.
Read More on RethinkTHC
- THC-amygdala-anxiety-brain
- anandamide-weed-withdrawal
- cannabinoid-receptors-recovery-time
- cannabis-developing-brain-teenagers
- cant-enjoy-anything-without-weed
- dopamine-recovery-after-quitting-weed
- endocannabinoid-system-explained-simply
- endocannabinoid-system-withdrawal
- nervous-system-weed-withdrawal-fight-flight
- teen-weed-use-under-18-effects-brain
- thc-brain-withdrawal
- thc-prefrontal-cortex-brain-effects
- weed-cortisol-stress-hormones
- weed-memory-loss-recovery
- weed-motivation-amotivational-syndrome
- weed-nervous-system-effects
- weed-reward-system-brain
Cite This Study
https://rethinkthc.com/research/RTHC-03554APA
Stiles, Erik; Alcover, Karl C; Stiles, Bryan; Oluwoye, Oladunni; McDonell, Michael G. (2021). Cannabis use and metabolic syndrome among clients with first episode psychosis.. Early intervention in psychiatry, 15(4), 1051-1055. https://doi.org/10.1111/eip.13030
MLA
Stiles, Erik, et al. "Cannabis use and metabolic syndrome among clients with first episode psychosis.." Early intervention in psychiatry, 2021. https://doi.org/10.1111/eip.13030
RethinkTHC
RethinkTHC Research Database. "Cannabis use and metabolic syndrome among clients with first..." RTHC-03554. Retrieved from https://rethinkthc.com/research/stiles-2021-cannabis-use-and-metabolic
Access the Original Study
Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.
This study breakdown was produced by the RethinkTHC research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.